Liu S, Zeng S, Xia L, Yu M, et al. Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy. Breast Cancer Res Treat 2020 Nov 9. pii: 10.1007/s10549-020-06015.
PMID: 33165709